FDA Warning Letters About Peptides Sold as "Research Chemicals"
FDA issues warning letters to companies selling peptides as "research chemicals" and warns consumers about the serious health consequences of using unapproved injectable peptides.
Hyaluronic Acid Products Containing Undeclared Ingredients
FDA is urging consumers to stop using and seek medical advice regarding certain hyaluronic acid products marketed for pain relief, as laboratory testing revealed hidden drug ingredients that pose severe health risks.
FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s
FDA issues 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products.
Certain Bodybuilding Products Put Consumers at Risk for Heart Attack, Stroke, Serious Liver Damage and More
FDA warns consumers about illegal bodybuilding dietary supplement products, which often contain SARMs.
FDA Seizes 7-OH Opioids to Protect American Consumers
FDA and DoJ seize thousands of 7-hydroxymitragynine (7-OH) products.
FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
FDA established a "green list" import alert to safeguard consumers from potentially dangerous GLP-1 active ingredients imported from overseas.
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
FDA continues to alert healthcare professionals and consumers about the risks of 7-hydroxymitragynine.
FDA Warns Consumers Not to Use Counterfeit Ozempic (Semaglutide) Found in U.S. Drug Supply Chain
Patients should only obtain Ozempic with a valid prescription through state-licensed pharmacies, according to FDA.
FDA Alerts Health Care Providers, Compounders and Consumers of Potential Risks Associated With Compounded Topical Finasteride Products
FDA has become aware of reports of adverse events involving compounded topical finasteride products.
Athlete Advisory: What’s New on the 2025 WADA Prohibited List?
Summary of changes to WADA Prohibited List